HEMODYNAMIC STABILITY WITH ETOMIDATE VS PROPOFOL AS INDUCTION AGENTS IN CORONARY ARTERY BYPASS GRAFT SURGERY
Main Article Content
Keywords
Etomidate, Propofol, Hemodynamic Stability, Anesthetic Induction, Coronary Artery Bypass Graft, Cardiac Anesthesia, Mean Arterial Pressure, Vasopressor Use.
Abstract
BACKGROUND
Maintaining hemodynamic stability during anesthetic induction is critical in patients undergoing CABG (Coronary Artery Bypass Graft) surgery due to their compromised cardiac function. Etomidate and propofol are commonly used induction agents, but they differ significantly in their cardiovascular effects.
AIM: The study aims to determine which induction agent minimises peri-induction cardiovascular fluctuations and maximises patient safety during anaesthesia induction by comparing the haemodynamic stability offered by etomidate and propofol in patients undergoing CABG surgery.
MATERIALS AND METHODS: This prospective study included 100 CABG patients randomized into two groups: etomidate (0.3 mg/kg, n=50) and propofol (2 mg/kg, n=50). MAP (Mean Arterial Pressure), HR (Heart Rate), hypotension incidence, and vasopressor use were assessed at baseline and post-induction.
RESULTS: Etomidate showed significantly better MAP stability at 1, 3, and 5 minutes post-induction (p < 0.001). Hypotension occurred in 6% of etomidate vs. 28% of propofol patients (p = 0.003). Vasopressors were needed in 4% vs. 22% respectively (p = 0.006). HR changes were not significant.
CONCLUSION
Etomidate provides superior hemodynamic stability compared to propofol and is preferred for induction in high-risk CABG patients.
References
[2] Forman SA. Clinical and molecular pharmacology of etomidate. Anesthesiology 2011;114(3):695-707.
[3] Larsen B, Seitz A, Larsen R. Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients: a comparison with etomidate. Anesth Analg 1988;67(12):1213-8.
[4] Larsen B, Seitz A, Larsen R. Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients: a comparison with etomidate. Anesth Analg 1988;67(12):1213-8.
[5] Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004;10(29):3639-49.
[6] Tekwani KL, Watts HF, Rzechula KH, et al. A comparison of the effects of etomidate and propofol on hemodynamics during induction of general anesthesia. Am J Emerg Med2013;31(2):313-7.
[7] Gooding JM, Corssen G. Etomidate induction for general anesthesia: a clinical comparison with thiopental. Anesth Analg 1977;56(1):40-3.
[8] Hildreth AN, Mejia VA, Maxwell RA, et al. Adrenocortical suppression following etomidate in trauma patients: a prospective randomized study. J Trauma 2008;65(3):573-9.
[9] Claeys MA, Gepts E, Camu F. Haemodynamic changes during anaesthesia induced and maintained with propofol. Br J Anaesth 1988;60(1):3-9.
[10] Larsen B, Seitz A, Larsen R. Effects of propofol on cardiovascular dynamics and coronary blood flow in geriatric patients: a comparison with etomidate. Anesth Analg 1988;67(12):1213-8.
[11] RyuJH, Lee C, Do SH. Recovery after etomidate induction in patients undergoing general anesthesia. Korean J Anesthesiol 2012;63(3):236-41.
[12] Tan CH, Onsiong MK. Clinical uses of etomidate. Anaesthesia 1998;53(7):592-601.
[13] Vinclair M, Broux C, Faure P, et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med 2008;34(4):714-9.
[14] Komatsu R, Ueda K, Sugawara M, et al. Etomidate and adrenal suppression: a single-center retrospective cohort study in cardiac surgery patients. J Cardiothorac Vasc Anesth 2017;31(2):536-42.
[15] Hohl CM, Kelly LE, Goehring B, et al. Etomidate versus alternative induction agents for endotracheal intubation: a systematic review. Ann Emerg Med 2018;71(3):389-39.